DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /CytoskeletonCytoskeleton
  5. /SelectinSelectin
  6. /Psi-697Psi-697
Chemical structure of CAS 851546-61-7

Psi-697

In Stock•Starting at $156 for 5 mg•Purity ≥ 99%
CAS No.851546-61-7
MDL No.N/A
MFC21H18ClNO3
MW367.80
InChI KeyDIEPFYNZGUUVHD-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg99%$156In Stock
10 mg99%$248In Stock
25 mg99%$494In Stock
50 mg99%$837In Stock
100 mg99%$1421In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.851546-61-7
Product NamePsi-697

Associated Conditions

scleritis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

P-selectin antagonism reduces thrombus formation in humans.

Journal of thrombosis and haemostasis : JTH • Vol. 7, Issue 11 • 2009
PMID: 19691482DOI: 10.1111/j.1538-7836.2009.03587.x

Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis.

The Journal of pharmacology and experimental therapeutics • Vol. 324, Issue 2 • 2008
PMID: 18024786DOI: 10.1124/jpet.107.128124

2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[H]quinoline-4-carboxylic acid (PSI-697): identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonists.

Journal of medicinal chemistry • Vol. 50, Issue 1 • 2007
PMID: 17201409DOI: 10.1021/jm060631p

Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation.

Thrombosis and haemostasis • Vol. 97, Issue 3 • 2007
PMID: 17334507

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact